|
WDR11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.59269999597956E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.26199999994636E-06 |
| Normal-vs-Stage2 |
2.412800E-04 |
| Normal-vs-Stage3 |
4.24330004467066E-09 |
| Normal-vs-Stage4 |
6.67339516979837E-11 |
| Stage1-vs-Stage2 |
8.931800E-01 |
| Stage1-vs-Stage3 |
4.041700E-02 |
| Stage1-vs-Stage4 |
6.829100E-04 |
| Stage2-vs-Stage3 |
1.232200E-01 |
| Stage2-vs-Stage4 |
8.955100E-03 |
| Stage3-vs-Stage4 |
1.746620E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.71899996856706E-09 |
| Normal-vs-AfricanAmerican |
2.160400E-04 |
| Normal-vs-Asian |
3.74640000000426E-05 |
| Caucasian-vs-AfricanAmerican |
9.607400E-01 |
| Caucasian-vs-Asian |
6.267800E-01 |
| AfricanAmerican-vs-Asian |
7.736800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.80409999664499E-08 |
| Normal-vs-Female |
4.43330000488018E-08 |
| Male-vs-Female |
3.183200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.28520000003607E-06 |
| Normal-vs-Age(41-60Yrs) |
7.4959000007091E-08 |
| Normal-vs-Age(61-80Yrs) |
2.23410001609636E-09 |
| Normal-vs-Age(81-100Yrs) |
5.488400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.877760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.207900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.321600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.443800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.398000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.208800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.854500E-02 |
| Classical-VS-Follicular |
6.468200E-01 |
| Classical-VS-Other |
4.249200E-01 |
| Classical-VS-Normal |
4.39999999768403E-08 |
| Tall-VS-Follicular |
3.615900E-02 |
| Tall-VS-Other |
8.327600E-01 |
| Tall-VS-Normal |
1.405799999743E-07 |
| Follicular-VS-Other |
4.521600E-01 |
| Follicular-VS-Normal |
1.639960E-04 |
| Other-VS-Normal |
5.605000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.94429999988976E-07 |
| Normal-vs-N1 |
6.49820000031553E-08 |
| N0-vs-N1 |
1.142820E-01 |
|
|
